Colleen O'Connell - Inst Biomed Engn, Univ New Brunswick

Colleen O'Connell, Xavier Rodrigue, Victoria Hodgkinson, Katie Henley,Jeremy Slayter, Alberto Aleman, Dorothy Drost,Aaron Izenberg, Beth Knowles,Hanns Lochmüller, Marianne Nury, Erin O'Ferrall, Homira Osman, Kerri Schellenberg,Christen Shoesmith,Christine Stables, Susi Vander Wyk, Grace Westbury

Journal of neuromuscular diseasespp.22143602251336076-22143602251336076, (2025)

Cited0Views0WOSBibtex

An Environmental Scan of Limb Loss Rehabilitation Centers Across Canada

Prosthetics and orthotics internationalno. 2 (2024): 248-255

Cited0Views0WOSBibtex

How to Break the News in Amyotrophic Lateral Sclerosis/motor Neuron Disease: Practical Guidelines from Experts

Colleen O'Connell,Melinda S Kavanaugh, Cathy Cummings,Angela Genge

Amyotrophic lateral sclerosis & frontotemporal degenerationno. 1-2 (2024): 5-14

Cited0Views0WOSBibtex

All Hands on Deck: the Multidisciplinary Rehabilitation Assessment and Management of Hand Function in Persons with Neuromuscular Disorders

Colleen O'Connell,Meiqi Guo, Beatrice Soucy, Marla Calder, Jeff Sparks,Stephanie Plamondon

MUSCLE & NERVE (2024)

Cited1Views0WOSBibtex

Associations Between Long-Term Exposures to Environmental Factors and the Development of Amyotrophic Lateral Sclerosis: A Matched Case-Control Study

Daniel Saucier,Mathieu Bélanger,Zikuan Liu,Colleen O'Connell

International Journal for Population Data Scienceno. 5 (2024)

Cited0Views0Bibtex

A Proof of Concept Study of the PIKfyve Inhibitor VRG50635 in Patients with Sporadic and Familial Amyotrophic Lateral Sclerosis

Diego Cadavid, Sujata Sankar, Payal Nanavati, Anil Tarachandani, Alistair Stewart,Irene Choi, Robert H. Scannevin,William Tracewell, Paula Sandler, Brian Shook, Robert Galemmo, Shane Rainses,Jeremy Hobart,Philip Van Damme,Monica Povedano,Juan Francisco Vazquez Costa,Pentti Tienari,Eino Solje,Manu Jokela,Angela Genge,Colleen O'Connell,Ruben van Eijk,Leonard van den Berg

ANNALS OF NEUROLOGY (2024): S268-S268

Cited0Views0Bibtex

CONNECT1-EDO51: a 12-Week Open-Label Phase 2 Study to Evaluate PGN-EDO51 Safety and Efficacy in People with Duchenne Amenable to Exon 51 Skipping

M. Mellion,H. McMillan,N. Chrestian,H. Gonorazky,C. O'Connell,S. Vacca, M. Peterson, B. Marcos, S. Batra,P. Lonkar,A. Holland,J. Foy,S. Lamore,B. Garg, S. Yu,J. Larkindale

NEUROMUSCULAR DISORDERS (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn